These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 21459312

  • 1. Linezolid-associated hypoglycemia in a 64-year-old man with type 2 diabetes.
    Bodnar T, Starr K, Halter JB.
    Am J Geriatr Pharmacother; 2011 Feb; 9(1):88-92. PubMed ID: 21459312
    [Abstract] [Full Text] [Related]

  • 2. Linezolid for the treatment of methicillin-resistant Staphylococcus aureus infections in children.
    Kaplan SL, Afghani B, Lopez P, Wu E, Fleishaker D, Edge-Padbury B, Naberhuis-Stehouwer S, Bruss JB.
    Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S178-85. PubMed ID: 14520144
    [Abstract] [Full Text] [Related]

  • 3. [Sideroblastic anemia after prolonged linezolid therapy].
    Kakimoto T, Nakazato T, Miura R, Kurai H, Yamashita D, Sagara Y, Ishida A.
    Rinsho Ketsueki; 2008 Nov; 49(11):1566-8. PubMed ID: 19047790
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Linezolid-induced reversible bicytopenia in a 4-year-old boy with methicillin-resistant Staphylococcus aureus bacteremia.
    Tavil B, Balci YI, Yildirim I, Tavil Y, Secmeer G, Ceyhan M, Tuncer M.
    Pediatr Hematol Oncol; 2008 Nov; 25(1):67-71. PubMed ID: 18231956
    [Abstract] [Full Text] [Related]

  • 6. Bell's palsy associated with linezolid therapy: case report and review of neuropathic adverse events.
    Thai XC, Bruno-Murtha LA.
    Pharmacotherapy; 2006 Aug; 26(8):1183-9. PubMed ID: 16863496
    [Abstract] [Full Text] [Related]

  • 7. Probable hypoglycemic adverse drug reaction associated with prickly pear cactus, glipizide, and metformin in a patient with type 2 diabetes mellitus.
    Sobieraj DM, Freyer CW.
    Ann Pharmacother; 2010 Aug; 44(7-8):1334-7. PubMed ID: 20516361
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics and pharmacodynamics of linezolid in obese patients with cellulitis.
    Stein GE, Schooley SL, Peloquin CA, Kak V, Havlichek DH, Citron DM, Tyrrell KL, Goldstein EJ.
    Ann Pharmacother; 2005 Mar; 39(3):427-32. PubMed ID: 15701775
    [Abstract] [Full Text] [Related]

  • 10. Severe and resistant hypoglycemia associated with concomitant gatifloxacin and glyburide therapy.
    LeBlanc M, Bélanger C, Cossette P.
    Pharmacotherapy; 2004 Jul; 24(7):926-31. PubMed ID: 15303456
    [Abstract] [Full Text] [Related]

  • 11. Clinical and economic outcomes of oral linezolid versus intravenous vancomycin in the treatment of MRSA-complicated, lower-extremity skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus.
    Sharpe JN, Shively EH, Polk HC.
    Am J Surg; 2005 Apr; 189(4):425-8. PubMed ID: 15820454
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of linezolid in methicillin-resistant Staphylococcus aureus (MRSA) complicated skin and soft tissue infection (cSSTI): a meta-analysis.
    Bounthavong M, Hsu DI.
    Curr Med Res Opin; 2010 Feb; 26(2):407-21. PubMed ID: 20001574
    [Abstract] [Full Text] [Related]

  • 13. Serotonin toxicity associated with concomitant use of linezolid.
    Bergeron L, Boulé M, Perreault S.
    Ann Pharmacother; 2005 May; 39(5):956-61. PubMed ID: 15827071
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of linezolid in liver transplant patients.
    Radunz S, Juntermanns B, Kaiser GM, Treckmann J, Mathe Z, Paul A, Saner FH.
    Transpl Infect Dis; 2011 Aug; 13(4):353-8. PubMed ID: 21355969
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Linezolid versus vancomycin for the treatment of infections caused by methicillin-resistant Staphylococcus aureus in Japan.
    Kohno S, Yamaguchi K, Aikawa N, Sumiyama Y, Odagiri S, Aoki N, Niki Y, Watanabe S, Furue M, Ito T, Croos-Dabrera R, Tack KJ.
    J Antimicrob Chemother; 2007 Dec; 60(6):1361-9. PubMed ID: 17913720
    [Abstract] [Full Text] [Related]

  • 17. Randomized, double-blind comparison of once-weekly dalbavancin versus twice-daily linezolid therapy for the treatment of complicated skin and skin structure infections.
    Jauregui LE, Babazadeh S, Seltzer E, Goldberg L, Krievins D, Frederick M, Krause D, Satilovs I, Endzinas Z, Breaux J, O'Riordan W.
    Clin Infect Dis; 2005 Nov 15; 41(10):1407-15. PubMed ID: 16231250
    [Abstract] [Full Text] [Related]

  • 18. Elevated creatine phosphokinase levels associated with linezolid therapy.
    Allison GW, Perla RJ, Belliveau PP, Angelis SM.
    Am J Health Syst Pharm; 2009 Jun 15; 66(12):1097-100. PubMed ID: 19498124
    [Abstract] [Full Text] [Related]

  • 19. Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections.
    Stevens DL, Herr D, Lampiris H, Hunt JL, Batts DH, Hafkin B.
    Clin Infect Dis; 2002 Jun 01; 34(11):1481-90. PubMed ID: 12015695
    [Abstract] [Full Text] [Related]

  • 20. Risk factors for anaemia in patients on prolonged linezolid therapy for chronic osteomyelitis: a case-control study.
    Senneville E, Legout L, Valette M, Yazdanpanah Y, Giraud F, Beltrand E, Obert G, Dubreuil L, Migaud H, Mouton Y.
    J Antimicrob Chemother; 2004 Oct 01; 54(4):798-802. PubMed ID: 15329363
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.